Autonomix Medical Launches Public Offering; Shares Drop

MT Newswires11/01 22:09

Autonomix Medical Reports New Topline Results From First 15 Patients' 7-Day Data Highlighting Significant Impact On Treatment Of Pancreatic Cancer Pain With Maintained Pain Reduction; 79% Responder Rate Achieved With Zero Opioid Use And Quality Of...

Benzinga10/31 20:36

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga10/31 20:09

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means From Lead-In Patients in Ongoing Human Clinical Trial

GlobeNewswire10/30 20:30

AMIS Stock Surges After RF Ablation Trial Unveils Positive Results

Zacks 10/29 23:00

Top Midday Gainers

MT Newswires10/29 02:37